Innovative implant from Nvision corrects hammertoe, and expands product offering to lower extremities
San Antonio, TX (US) / Thornton Cleveleys (UK), March 11, 2019 – The Vector™ Hammertoe Correction System, a bioimplant from Nvision Biomedical Technologies, a medical device and biologics company, has been cleared by the FDA for use in the US. It is the first foot and ankle implant to be made from the advanced, biocompatible PEEK-OPTIMA™ HA Enhanced, a polymer from Invibio Biomaterial Solutions™.

LOS ANGELES – Nvision Biomedical Technologies, a San Antonio-based medical device and biologics manufacturer, debuted its focus® Pedicle Screw System today at the North American Spine Society (NASS) Annual Meeting, held at the Los Angeles Convention Center, September 26-29. 

Nvision Biomedical Technologies, a San Antonio-based medical device and biologics manufacturer, has received clearance from the U.S. Food and Drug Administration (FDA) for its focus® Pedicle Screw System.

Earlier this month, renowned spine surgeon, Zeshan Hyder, DO, became one of the first surgeons to perform an implant surgery utilizing medical devices from Nvision Biomedical Technologies with Structural Encoding®. On Wednesday, Dr. Hyder will present on his experience and benefits of using the ground-breaking technology at the 2017 NASS (North American Spine Society) Conference in Orlando, Fla.

Zeshan Hyder, DO, of Bone & Joint Specialists in Merrillville, Ind.; Frank K. Kuwamura, III, MD, of Innovative Spine in San Antonio; and Larry M. Kjeldgaard, DO, of Cervical Spine Specialist in Fort Worth are the first surgeons to implant medical devices with Structural Encoding® technology. The Structural Encoding technology advances patient care by providing permanent marking embedded within the device that is accessible through an x-ray image.

Industry veteran tabbed to lead Nvision’s next phase of growth and development of surgical device and tissue product sales.

Nvision Biomedical Technologies is the first company to launch devices with Structural Encoding® technology developed by Watershed Idea Foundry.  

Fountainhead Investment Partners, a San Antonio-based venture capital firm, has made an investment in Nvision Biomedical Technologies. Terms of the transaction were not disclosed.

Nvision, a medical device and biologics developer and manufacturer focused on spinal implants, announces its launch with four initial proprietary products for distribution. Nvision will provide products that combine implants, instrumentation, biologics and high-touch customer service to deliver a complete solution for surgeons, facilities and distributors.